Good morning, and welcome to the DLH Holdings Fiscal 2022 first quarter earnings call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your touchtone phone. To withdraw your question, please press star then two. Please note this event is being recorded. I would now like to turn the conference over to Chris Witty, Investor Relations Advisor. Please go ahead.
Thank you, and good morning, everyone. On the call with me today is Zach Parker, President and Chief Executive Officer, and Kathryn JohnBull, Chief Financial Officer. The company's earnings release and PowerPoint presentation are available on our website under the investor page. I would now like to provide a brief safe harbor statement, which is also shown on slide two of the presentation. This call may include forward-looking statements that relate to the company's outlook for fiscal 2022 and beyond. These forward-looking statements are subject to various risks and uncertainties that could cause actual results and events to differ materially from these statements. Please refer to the risk factors contained in the company's annual report on Form 10-K and in our other filings with the Securities and Exchange Commission. We do not undertake any duty to update any forward-looking statements.
On today's call, we will be referencing both GAAP and non-GAAP financial measures. A reconciliation of our non-GAAP results to our reported GAAP results is included in our earnings release and in the investor presentation on DLH's website. President and CEO, Zach Parker, will speak next, followed by CFO Kathryn JohnBull. After which, we'll open it up for questions. With that, I'd like to now turn the call over to Zach. Please go ahead, Zach.
Thank you, Chris, and good morning, everyone. Welcome to our fiscal year 2022 first quarter conference call, and Happy New Year. As we hope you will agree, fiscal 2022 is off to a great start at DLH. I wanna first give credit to our tremendous committed leadership team and workforce for keeping focused on the missions of our customers. None of us would have predicted two years ago that we would be discussing great results despite the challenges of the pandemic. Beginning with slide three, I'll first provide a high-level overview of the quarter, which represented outstanding results for the company. Buoyed by our recent short-term contracts with FEMA, providing pandemic-related assistance in Alaska, revenue rose to $152.8 million in Q1.
Even excluding the $91.1 million of FEMA-related work, we saw a revenue growth of 7% year-over-year as our programs remained strong and in strong demand despite an ongoing continuing resolution in Washington. We posted operating income of $11.2 million, which equates to 7.3% of sales, including the impact of our lower margin Alaska contracts. First quarter earnings were $0.55 per share or $0.22 without the FEMA work, reflecting the value of our technology offerings and highly credentialed staff. A reconciliation of the numbers is in the back of this presentation. We also paid down an additional $3.9 million of our term debt loan this quarter, further delevering the balance sheet and closed out December with a backlog of $633.6 million.
Turning to slide four, I'd like to give an update of our markets, applications, and advanced capabilities. We continue to serve the federal arenas that will define the next decade of public and military health investment, and we've built a strong and growing position across a number of enhanced emerging technology offerings. Demand for our services in existing and adjacent markets continues to expand due to an increased emphasis across the board on advanced data analytics and digital transformation. DLH is an established provider of innovative solutions for medical assistance and diagnostics, including telehealth and pharmaceutical systems. With our scientific and research capabilities, we can help the federal government effectively assess and respond to current and future health challenges across the nation.
At the same time, our advanced capabilities in digital transformation include experience in IT infrastructure and modernization, cloud-based solutions, and continuous software development, all with a healthcare focus. We possess robust capabilities in data analytics and cybersecurity, providing a large-scale management services that leverage technology with highly credentialed subject matter experts. These focus areas in total are expected to benefit from the high demand going forward. DLH believes we have the right people, proper expertise, and customer relationships in place to drive growth in the quarters and years to come. In closing, the company is stepping up to the next level in terms of its offerings and the breadth of innovative solutions that we bring to bear.
While the FEMA business will come to a close in quarter two, DLH is well-positioned to have a highly successful year with a strong balance sheet, longstanding partnerships with key agencies, and an exciting array of technology applications. Although we are mindful that the federal budgetary uncertainties need to be resolved in the near future, we're well on our way to another year of solid organic growth and customer expansion, and continue looking at possible acquisition opportunities that can further accelerate our top-line growth going forward. With that, I'd now like to turn the call over to our Chief Financial Officer, Kathryn JohnBull. Kathryn?
Zach, good morning, everyone. We're pleased to report such a great start to fiscal 2022. Turning to slide six, we posted revenue of $152.8 million for the three months ended December 31st, 2021 versus $57.9 million in the prior year's first quarter. The growth reflects the impact of approximately $91.1 million in revenue tied to the Alaska FEMA contracts, as Zach discussed, along with a 7% revenue increase across the other parts of our business. The majority of the Alaska contracts have been fulfilled such that we see approximately $30 million of additional revenue during Q2 and none thereafter. If additional revenue is awarded based on pandemic needs in the region, we will let our investors know.
Turning to slide seven, income from operations was $11.2 million for the fiscal 2022 first quarter versus $3.6 million last year. Again, reflecting the additional short-term FEMA business. Operating margins improved to 7.3% from 6.3% in fiscal 2021, with the current year results including the impact from lower margin Alaska work. At the same time, reflecting a larger contribution of time and materials programs in the remaining business, which generally yields stronger returns than cost reimbursable contracts. Interest expense was $0.7 million in the first fiscal quarter of 2022 versus $1.1 million in the prior year period, reflecting lower debt outstanding. DLH recorded a provision of $2.7 million and $0.7 million for tax expense during the first quarters of fiscal 2022 and fiscal 2021, respectively.
We reported net income in the first quarter of approximately $7.8 million or $0.55 per diluted share versus $1.8 million or $0.13 a share last year. Excluding the Alaska business, non-GAAP earnings for the first fiscal quarter of 2022 were $3.1 million or $0.22 per diluted share. A reconciliation of all these results is included in the back of this presentation. Turning to slide eight, EBITDA for the first quarter of fiscal 2022 was $13.2 million versus $5.7 million in the prior year period due to the reasons I discussed above.
As a percent of sales or revenue rose to 8.6% this quarter versus 9.8% last year, but excluding $6.3 million related to our Alaska business, EBITDA for our ongoing contract portfolio was approximately $6.8 million or 11.1% as a percent of revenue in the fiscal 2022 first quarter. A reconciliation of GAAP net income to EBITDA is provided in our earnings statement and at the back of this presentation. Slide nine gives an updated snapshot of our debt position at the end of the first quarter. As of December 31st, we had approximately $42.9 million of debt outstanding under our credit facilities versus $46.8 million at the end of fiscal 2021.
We now have satisfied all mandatory principal payments on the loan facility through March 31st, 2024, but we will continue to reduce debt when feasible to strengthen the balance sheet going forward. This concludes my discussion of the financial statements. With that, I would now like to turn the call over to our operator for questions.
We will now begin the question-and-answer session. To ask a question, you may press star then one on your touch tone phone. If you are using a speakerphone, please pick up your handset before pressing the keys. To withdraw your question, please press star then two. At this time, we will pause momentarily to assemble our roster. Our first question today comes from Brian Kinstlinger with Alliance Global Partners. Please go ahead.
Hey, great, thanks. Great first quarter here. Did I hear right, excluding the FEMA contracts that your EBITDA margin was 11% versus 8% a year ago? If that's right, can you just describe the factors that drove that? I take it some of it's mix, but I also figure you're paying your people more in this market. Just maybe go through the dynamics if I did hear that right.
Yes, you did hear that right, Brian. By the way, good morning. Thanks for joining us. EBITDA as a percent of revenue for the three months last year was 9.8% and 11.1% this three months, excluding Alaska. The improvement comes from a couple things, as you suggest. It's the contract mix, where we had a healthier proportion of the revenue delivered from time and materials largely, and a little bit of fixed fee for service contracts versus last year where a stronger portion of the mix was from cost reimbursable work. Secondarily, the operating leverage we got on our indirect expenses improved as the revenue base grew as well. The two of those together yielded that strong EBITDA performance for the quarter.
Great. Can you talk about your pipeline? Are there any other short or long-term contracts that are COVID related? Of course, not including the existing Alaska or CDC contracts you have where you're doing research on the long-term impacts. I'm just wondering, you know, is there a pipeline of similar contracts, or are those slowly subsiding as Omicron seems to be getting a little bit better?
Yeah, great question, Brian, and again, thank you for your participation. The answer is yes to both. We are in discussions on short-term impact. Certainly as Omicron starts to recede a bit, there is a look at potential additional variants and what sort of therapeutics we believe might be more germane as COVID continues to morph. While at the same time, we are seeing that the government is starting to think about longer-term research projects associated with it as well. There's a little bit of both.
The biggest challenge has been for all of us in GovCon is the government acquisition folks being able to get those contracts out in a, as you might imagine, in a CR environment. It's very difficult to get new contracts out. Sometimes they're using more novel contracts, certainly for large buys, things like OTAs. We're hopeful that the discussions that we're hearing and the customers' interests will turn into solicitations.
Great. I have two more. The first one is, as it relates to challenges in recruiting talent, has that challenge subsided at all? And secondarily, has it caused any lost revenue? Meaning, have you been able to fill and or fully staff all your contracts?
We have seen some erosion as the rest of the nation has. As you know, the Great Resignation has placed a real challenge for the labor market across the field. We're seeing some of that. We're experiencing some of that on some of our contracts, not only for a smaller labor base, but also from time to time, COVID-induced absences. We're continuing to manage that. As you know, we've stepped up our investment in human capital management within the business. That involves both retention and attracting of new talent. Yeah, we have seen a small impact thus far through Q1 of what we're seeing across the nation.
Great. Lastly, if you can just talk about your M&A pipeline, and as you look, what are management's priorities in terms of what you hope a target will bring to DLH?
Yeah. Yeah. Let me just kick off we are opening our aperture in that regard. Strategically, Kathryn and I have really felt that, as you may be reading, that the conclusion of this last fiscal year really represents the having satisfied our strategic plan, in particular phase, the first phase of our strategic acquisition plan. We're looking at expanding our opportunities in the M&A arena. Kathryn has led some activity over the recent month or so, and can talk about the pipeline more specifically. Kathryn.
Yeah. The pipeline we expect to continue to be quite healthy. There is quite a bit of activity out there. And our focus as we've indicated from our perspective, we closed our first phase of our acquisition strategy, which was principally focused on market presence in our target markets and had the beneficial effect of having some improvement and enhancing of our technology capabilities as well. From a perspective of our phase two acquisition strategy, we're gonna flip around those priorities. We think we've got good coverage in the relevant markets, although as Zach indicated, there are some definite adjacent markets that we continue to be keeping an eye on.
Our primary emphasis from an acquisition strategy perspective is adding capabilities and really extending our reach in those relevant technologies that benefit our current customers and any potential future ones. Digital transformation, AI, ML, the things that are really relevant, modeling and simulation, those things are applicable across the set of markets that we currently play in and those that are near adjacent. That's really gonna be the primary lens through which we evaluate acquisition, competitive acquisition opportunities.
Great. Thanks so much, guys. Nice quarter.
Thanks for joining us, Brian.
Again, if you'd like to ask a question today, it is star then one. Star then one to ask a question. Our next question comes from Joe Gomes with Noble Capital. Please go ahead.
Thanks. Good morning. Congratulations on a great quarter.
Thank you, Joe.
Thank you.
Good morning to you, my friend.
Great to hear from you.
If we could just take a step back for a second on FEMA. Just wanna kinda drill down on that just for a second here. You know, you got the two initial contracts. They were $107 million valued up to. Then you have the $35 million extension, so that's $142 million. You did $91 million in the quarter, so that leaves, let's call it, you know, $50 million from the headline. You're saying that in the second quarter, you're thinking $30 million and then that's it. What happened to the other $20 million? Is that just not being filled or is there something else there?
Yeah. I think the awarded values are really function as an estimate at a point in time. As we all know, COVID is a fast-moving environment. From our perspective, you know, our current visibility on the program and the needs from the customer in terms of the support we're providing, we expect to deliver an additional $30 million. Though they have funded or they have earmarked more than that in the event that they have additional surges or other variants or other things that could happen. You know, we can only share with you the visibility based on the trend line as we see it today.
Right.
To the extent that varies. We'll have to provide a further update.
It's probably worth noting also, Joe, that you know the way this program is working through FEMA, it is the state's actually drawing upon federal money that has been obligated for this effort.
Mm-hmm.
It's contingent. The states are actually working off of, as Kathryn indicated, predictions and contingencies as well. You know, it could operate in either direction, like Kathryn indicated. Right now we're seeing with the cessation of Omicron that there's new indication, and particularly in Alaska, that it will be accelerating. You know, we'll all stay tuned. We certainly hope that remains the case.
Mm-hmm.
Okay, great. On that continuing resolution, since this seems to be dragging on a little bit longer than normal here. You know what, from your perspective or from your looking at the potential programs that you were hoping to be awarded, you know, what ones are most at risk of continuing to be pushed to the right? Does this have, you know, as this continues to go on, you know, an impact on your two big VA contracts which are currently operating under bridges? I would think that if the continuing resolution is extended, you know, maybe it then for you guys that you will see just those two contracts also extended out another year. I wonder if you might just give me a little comment on that.
Sure. With regard to the CR, first of all, we're, you know, we have rated it as, from a company standpoint, neutral, to slightly positive. Largely because the agencies that we serve are very strong with their mission and our budget stability is very strong accordingly. Both sides of the aisle are committed to the type of programs that we have in place supporting veterans, military, and the underserved community. Having said that, we're, you know, 12 of the last 13 budgets have, we've had to deal with CRs. And we're seeing frustration largely on the civilian side of the house. The DoD community and our DHA business is really pretty good and has been pretty good at spending against the budget.
While in recent years, the civilian agencies have had challenges in executing and getting the full budgetary spend. We've seen some of that impact. COVID of course accelerates that because the CR, during the CR period, the acquisition community had to do more on COVID than the steady-state business. We have continued to see two or three major programs slip to the right, new business opportunities for us. You usually find that when there's a case where there's some evolving scope in the work, and it could be perceived as new. Again, we can only be hopeful that a couple of those requests for proposals will come out in the near term.
We are getting good body language, good vibes from those customers that we should see something this fiscal year for a couple of our major programs. We're on our third year in a couple of cases for things slipping to the right. Of course, our CMOP contracts, as you referred to with the VA, they're on their fifth year of sole source bridges. You know, our first one expired in November of 2016. We're optimistic that we're gonna continue on that business with the CR. We've, you know, these are missions that we have to address every day and every week to ensure that we get the appropriate services and products to our veterans and our clients remain just as vigorous.
We remain very optimistic that we'll continue with the VA support. We're hopeful that we'll see some of our larger programs that have slipped to the right start to come back this fiscal year.
Okay. Thank you for that color, Zach. Maybe you could give us just a little more detail on, you know, what drove the 7% ex Alaska revenue increase. I noticed your revenues with Health and Human Services were up almost 15% year-over-year to $23.1 billion. What are those, you know, kind of color those contracts that are driving that type of revenue increase?
Yes. It is, in general, expansion on current contracts as well as some of the awards we had made in fiscal 2021, like the CDC DHAP program that we announced last August, as well as a bit of a starting to return to, I hesitate to call it normal.
Mm-hmm.
Maybe I'll put air quotes around the word normal return to activities in our Head Start program. So those kind of things that are both expanding on current programs as well as starting to return to some of the more normal operating patterns as well as the awards that we had late in fiscal 2021.
Okay, great. Anything new on that you can share with us on InfiniByte? You know, that program, it's something you've talked about a lot in the past and you know, how is that you know, rolling out here? You know, are you hitting internal plans that you had for that? Maybe just give us a little more detail on that product.
Yeah, no, I appreciate that. Yeah, it's still a very exciting part of our toolkit for us. As we may have shared earlier, just relatively recently, we just added some resources to really focus on the GovCon market for that program. On the government side, there's been some slippage from some of the secure data analytics contracts and the cloud-based hosting contracts. You know, things such as CMMC, et cetera, that were to be incorporated in the contracts, the government is redefining some of those cybersecurity requirements. In the meantime, we're looking to try to take InfiniByte for a spin and not wait passively for that.
We've started to build a pretty good pipeline there. Our current customers, of course, that we've been hosting for quite some time, are really getting some tremendous benefits. We're also looking at very soon completing an audit that should get our system fully certified externally. Kathryn, you wanna add anything to that?
I think that's exactly right. We're in that final phase of going from being on the market to being fully federally certified through GSA.
Okay, great. Thanks for the update. One last one for me, if I may. Kathryn
Okay, sure. Yeah. You know, we continue the pattern that we've seen in the last couple of years of our first quarter, which happens to end right around the year-end holidays. Particularly this year, with the way the calendar fell, I think people even exited a little bit earlier than they normally do for the Christmas and New Year holidays. As per that trend, we did have a peak in Q1. As per our usual trend, that's already clearing and the congestion's cleared, and we've had a very healthy January and looks like a good start to February based on this morning in collection.
I expect our full-year trend to be very much in line with our normal cash generation, strong cash generation that we generally deliver. The only variable for us this year is that we've moved from being able to shield our earnings with our NOLs. We fully consumed those during fiscal 2021, so we will be tax-paying in fiscal 2022. You know that old saying, you gotta be making money to pay taxes. We are among the tax-paying population now. We still nonetheless expect our net return, free cash flow to be very strong.
Kind of strange to be excited about having to pay taxes, right?
Zach, Kathryn, thank you very much again. Great quarter. Looking forward to seeing how the rest of the year plays out. Thank you.
Thank you, Joe.
Thank you, Joe.
Thanks for joining us.
Again, if you'd like to ask a question, it is star then one. Star then one to ask a question. The next question today comes from Victor Hernandez with Hernandez Capital. Please go ahead.
Thank you. Congratulations on a great quarter. I had, I think a simple question. On the statement of cash flows that you released, you had a line for deferred revenue. I wanted to see if you can give any details of what that line represents and what the impact would be on the full year.
Sure. Thank you for joining, Victor. Welcome.
Welcome, Victor.
The deferred revenue and the use of cash for performance of deferred revenue really reflects the fact that right before the end of last fiscal year, we collected a very large advanced payment from the State of Alaska for these FEMA contracts that we've talked about so much on this call. Q1's results just reflect the fact that we had to, you know, perform the obligations that we got the advanced payment for. We consumed that advanced payment in the quarter, and we'll fully deliver against that by the time the program executes in Q2.
Excellent. Thank you.
You betcha.
Thanks for joining.
At this time, there are no further questions in the question queue. Now I would like to turn the conference over to Mr. Parker for any closing remarks.
Well, thank you. I'd like to express my appreciation for those of you that are engaged both live and via the website, and also for those of you who will be checking it out offline. We are looking forward to sharing additional information with you at our annual meeting of the shareholders, which is scheduled for March 10 th. We're scheduled to be in New York, provided that the pandemic allows us. We will look forward to meeting with not only you all, but with our board of directors at that session, and we'll give you additional color around the strategy and the business. Thank you all for joining us today. Have a blessed day.
The conference has now concluded. Thank you for attending today's presentation. You may now disconnect. The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.